Psychosocial stress but not hypertensive status associated with angiogenesis in Africans

Blood Pressure

Volumn 23, Issue 5, 2014, Pages 307-314

  Venter, Paul Cristiaan ^a   Malan, Leoné ^a   Schutte, Aletta Elisabeth ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Africans; Angiogenesis; Cardiovascular; Urban

Indexed keywords

ANGIOPOIETIN 2; VASCULOTROPIN A; BIOLOGICAL MARKER; VEGFA PROTEIN, HUMAN;

ADULT; AFRICAN; ALCOHOL CONSUMPTION; ANGIOGENESIS; ARTERIAL STIFFNESS; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HEART RATE; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PROTEIN BLOOD LEVEL; PULSE WAVE; RURAL AREA; SMOKING; SOUTH AFRICA; SYSTOLIC BLOOD PRESSURE; URBAN AREA; BLACK PERSON; BLOOD; GENE EXPRESSION; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOLOGY; RISK FACTOR; RURAL POPULATION; STATISTICAL MODEL; URBAN POPULATION; URBANIZATION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL POPULATION; SOUTH AFRICA; STRESS, PSYCHOLOGICAL; URBAN POPULATION; URBANIZATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907059055     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2014.901008     Document Type: Article

References (38)

1. Dura OK, Li S, Jurkovitz C, Bakris G, Brown W, Chen SC, et al. Race and sex differences in hypertension control in CKD: Results from the kidney early evaluation program (KEEP). Am J Kidney Dis. 2008;51:192-198.
2. Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among U.S. adults: The third national health and nutrition examination survey mortality follow-up study. Ann Epidemiol. 2008;18:302-309.
3. Morenoff JD, House JS, Hansen BB, Williams DR, Kaplan GA, Hunte HE. Understanding social disparities in hypertension prevalence, awareness, treatment, and control: The role of neighbourhood context. Soc Sci Med. 2007; 65:1853-1866.
4. Opie LH, Mayosi BM. Cardiovascular disease in sub-Saharan Africa. Circulation. 2005;112:3536-3540.
5. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005;112:3562-3568.
6. Grady SC, Ramirez IJ. Mediating medical risk factors in the residential segregation and low birth weight relationship by race in New York City. Health Place. 2008;14(4):661-677.
7. Longo-Mbenza B, Lukoki Luila E, M'buyamba-Kabangu JR. Nutritional status, socio-economic status, heart rate, and blood pressure in African school children and adolescents. Int J Cardiol. 2007;121:171-177.
8. Niakara N, Fournet F, Gary J, Harang M, Nebie LV, Salem G. Hypertension, urbanization, social and spatial disparities: A cross-sectional population-based survey in a West African urban environment (Ouagadougou, Burkina Faso). Royal Soc Trop Med Hygiene. 2007;101:1136-1142.
9. Pepine CJ, Kowey PR, Kupfer S, Kolloch RE, Benetos A, Mancia G, et al. Predictors of adverse outcome among patients with hypertension and coronary artery disease. J Am Coll Cardiol. 2006;47:547-551.
10. Malan L, Schutte AE, Malan NT, Wissing MP, Vorster HH, Steyn HS, et al. Specific coping strategies of Africans during urbanization: Comparing cardiovascular responses and perception of health data. Biol Psychol. 2006;72:305-310.
11. Malan L, Hamer M, Schlaich MP, Lambert GW, Harvey BH, Reimann M, et al. Facilitated defensive coping, silent ischae-mia and ECG left-ventricular hypertrophy: The SABPA study. J Hypertens. 2012;30:543-550.
12. Malan L, Malan NT, Maria PW, Seedat YK. Coping with urbanization: A cardiometabolic risk? the THUSA study. Biol Psychol. 2008;79:323-328.
13. Otrock ZK, Mahfouz RA, Makarem JA, Shamseddine AI. Understanding the biology of angiogenesis: Review of the most important molecular mechanisms. Blood Cells Mol Dis. 2007;39:212-220.
14. Eaton CB, Gramling R, Parker DR, Roberts MB, Lu B, Ridker PM. Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England. Atherosclerosis. 2008;1-7.
15. Felmeden DC, Spencer CG, Belgore FM, Blann AD, Beevers DG, Lip GY. Endothelial damage and angiogenesis in hypertensive patients: Relationship to cardiovascular risk factors and risk factor management. Am J Hypertens. 2003; 16:11-20.
16. Nadar SK, Blann A, Beevers DG, Lip GY. Abnormal angi-opoietins 1 & 2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: Relationship to target organ damage [a sub-study of the Anglo-Scandinavian cardiac outcomes trial (ASCOT)]. J Intern Med. 2005;258: 336-343.
17. Li C, Xu Q. Mechanical stress-initiated signal transduction in vascular smooth muscle cells in vitro and in vivo. Cell Signal. 2007;19:881-891.
18. Korff T, Kimmina S, Martiny-Baron G, Augustin HG. Blood vessel maturation in a 3-dimensional spheroidal co culture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 2001;15:447-457.
19. Peters S, Cree IA, Alexander R, Turowski P, Ockrim Z, Patel J, et al. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability. Cytokine. 2007;40:144-150.
20. Kruger A. Prospective Urban and Rural Epidemiological (PURE) study protocol and instruction manual for South Africa, adapted from original edition, North West University: Potchefstroom. 2005:53.
21. De Roy PG. Helsinki and the declaration of Helsinki. WMJ. 2004;50:9-11.
22. Kruger HS, Venter CS, Vorster HH, Margetts BM. Physical inactivity is the major determinant of obesity in black women in the North West province, South Africa: The THUSA study. Nutr Afr. 2002;18:422-27.
23. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The taskforce for the management of arterial hypertension of the European society of hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the joint national committee on the prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. Hypertension. 2003;42:1206-1252.
25. World Health Organization. Obesity: Preventing and managing the global epidemic: Report of a WHO consultation. World Health Organ Tech Rep Ser. 2003.
26. Asmar R. Arterial stiffness and pulse wave velocity. Clin Appl. 1999:37-38.
27. Nichols WW. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens. 2005;18:3-10.
28. Safar ME. Stiffness of wall material in human hypertension. Biol Arterial Wall. 1999:215-233.
29. Lim HS, Lip GY, Blann AD. Angiopoietin-1 and angiopoie-tin-2 in diabetes mellitus: Relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis. 2005;180:113-118.
30. Smulyan H, Safar ME. Systolic blood pressure revised. JACC. 1997;29:1407-1413.
31. Yeragani VK, Tancer M, Seema KP, Josyula K, Desai N. Increased pulse-wave velocity in patients with anxiety: Implications for autonomic dysfunction. J Psychosom Res. 2006;61:25-31.
32. Tataranni PA. Relationship between subclinical inflammation, obesity, diabetes and related disorders. Dis Mech. 2005;2:303-306.
33. Sainani GS. Role of diet, exercise and drugs in modulation of endothelial cell dysfunction. J Ass Phys India. 2012;60:14-19.
34. Khazaei M, Moien-afshari F, Laher I. Vascular endothelial function in health and diseases. Pathophysiology. 2008; 15:49-67.
35. Torng P-L, Su TC, Sung FC, Chien KL, Huang SC, Chow SN, et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight-the Chin-Shan community cardiovascular cohort study. Atherosclerosis. 2002;161:409-415.
36. Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor Tie-2 levels in congestive heart failure. J Am Coll Cardiol. 2004;43:423-428.
37. Lim HS, Freestone B, Blann AD, Lip GY, Chong AY. Plasma vascular endothelial growth factor, angiopoietin-1, and angi-opoietin-2 in diabetes: Implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care. 2004;27:2918-2924.
38. Banegas JR, de la Sierra A, Segura J, Gorostidi M, de la Cruz J, Rodriguez-Artalejo F, et al. Control of hypertension in coronary heart disease. Int J Cardiol. 2009;134:245-247.